Clinical Trial Update: Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP) [NA]

View source ↗

Summary

Clinical trial update indicating completion of the SHARP program aimed at strengthening HPV vaccination uptake and adolescent health services in Nigeria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)
• Gardasil (human papillomavirus vaccine)
• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Human Papillomavirus (HPV) Vaccine, Human Papillomavirus (HPV) Vaccines | NA | Status: COMPLETED